Alerts will be sent to your verified email
Verify Email
BIOGEN
|
Biogen Pharmachem
|
Dhanalaxmi Roto Spin
|
Filtra Consultants
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.21 % | 20.43 % | 14.65 % |
|
5yr average Equity Multiplier
|
1.01 | 1.65 | 1.87 |
|
5yr Average Asset Turnover Ratio
|
0.02 | 2.43 | 2.4 |
|
5yr Avg Net Profit Margin
|
-19.83 % | 5.25 % | 3.25 % |
|
Price to Book
|
0.83 | 1.35 | 0.0 |
|
P/E
|
62.51 | 7.68 | 26.7 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 8.07 Days | 27.67 Days |
|
Inventory Days
|
0.0 | 4.2 Days | 52.76 Days |
|
Days Receivable
|
0.0 | 51.03 Days | 31.44 Days |
|
Days Payable
|
1109.22 Days | 42.28 Days | 64.82 Days |
|
5yr Average Interest Coverage Ratio
|
902.8 | 13.94 | 63.11 |
|
5yr Avg ROCE
|
0.21 % | 29.7 % | 20.36 % |
|
5yr Avg Operating Profit Margin
|
-19.88 % | 4.13 % | 4.36 % |
|
5 yr average Debt to Equity
|
0.0 | 0.1 | 0.02 |
|
5yr CAGR Net Profit
|
n/a | 16.09 % | 13.93 % |
|
5yr Average Return on Assets
|
0.21 % | 12.42 % | 7.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 47.64 % | 72.45 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.73 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biogen Pharmachem
|
Dhanalaxmi Roto Spin
|
Filtra Consultants
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|